Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022)

Steven Simoens; David Dodwell; Michael Hartevelt; Peter Lindgren; Michele Pistollato; Lisa G. Pont; Caridad Pontes; Alexander Roediger; Antun Sablek; Eric Van Ganse; Qinyi Wang; Chris Wenger; Tim Wilsdon; Entela Xoxi; Brian Godman

doi:10.3389/fphar.2025.1693232

Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022)

Steven Simoens
, David Dodwell
, Michael Hartevelt
, Peter Lindgren
, Michele Pistollato
, Lisa G. Pont
, Caridad Pontes
, Alexander Roediger
, Antun Sablek
, Eric Van Ganse
, Qinyi Wang
, Chris Wenger
, Tim Wilsdon
, Entela Xoxi
, Brian Godman

KU Leuven
University of Oxford
Merck
Swedish Institute for Health Economics
Karolinska Institutet
Charles River Associates
University of Technology Sydney
Autonomous University of Barcelona
Universite Claude Bernard Lyon 1
Aquantic AG
Catholic University of the Sacred Heart
University of Strathclyde
Sefako Makgatho Health Sciences University

Research output: Contribution to journal › Comment/debate

Abstract

Author Entela Xoxi was erroneously assigned to affiliation Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom. This affiliation has now been removed for author Entela Xoxi. Author Lisa G. Pont was erroneously spelled as Lisa Pont. The original article has been updated.

Original language	English
Article number	1693232
Journal	Frontiers in Pharmacology
Volume	16
DOIs	https://doi.org/10.3389/fphar.2025.1693232
State	Published - 2025
Externally published	Yes

Keywords

Australia
Europe
individual patient-level healthcare data
oncology combination therapies
pharmaceutical policy
pricing and reimbursement
utilization tracking

Access to Document

10.3389/fphar.2025.1693232

Fingerprint

Dive into the research topics of 'Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022)'. Together they form a unique fingerprint.

Cite this

Simoens, S., Dodwell, D., Hartevelt, M., Lindgren, P., Pistollato, M., Pont, L. G., Pontes, C., Roediger, A., Sablek, A., Van Ganse, E., Wang, Q., Wenger, C., Wilsdon, T., Xoxi, E., & Godman, B. (2025). Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022). Frontiers in Pharmacology, 16, Article 1693232. https://doi.org/10.3389/fphar.2025.1693232

@article{2565420150f44eee9886ed2111f3c6c2,

title = "Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022)",

abstract = "Author Entela Xoxi was erroneously assigned to affiliation Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom. This affiliation has now been removed for author Entela Xoxi. Author Lisa G. Pont was erroneously spelled as Lisa Pont. The original article has been updated.",

keywords = "Australia, Europe, individual patient-level healthcare data, oncology combination therapies, pharmaceutical policy, pricing and reimbursement, utilization tracking",

author = "Steven Simoens and David Dodwell and Michael Hartevelt and Peter Lindgren and Michele Pistollato and Pont, \{Lisa G.\} and Caridad Pontes and Alexander Roediger and Antun Sablek and \{Van Ganse\}, Eric and Qinyi Wang and Chris Wenger and Tim Wilsdon and Entela Xoxi and Brian Godman",

note = "Publisher Copyright: Copyright {\textcopyright} 2025 Simoens, Dodwell, Hartevelt, Lindgren, Pistollato, Pont, Pontes, Roediger, Sablek, Van Ganse, Wang, Wenger, Wilsdon, Xoxi and Godman.",

year = "2025",

doi = "10.3389/fphar.2025.1693232",

language = "English",

volume = "16",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

publisher = "Frontiers Media SA",

}

Simoens, S, Dodwell, D, Hartevelt, M, Lindgren, P, Pistollato, M, Pont, LG, Pontes, C, Roediger, A, Sablek, A, Van Ganse, E, Wang, Q, Wenger, C, Wilsdon, T, Xoxi, E & Godman, B 2025, 'Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022)', Frontiers in Pharmacology, vol. 16, 1693232. https://doi.org/10.3389/fphar.2025.1693232

Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022). / Simoens, Steven; Dodwell, David; Hartevelt, Michael et al.
In: Frontiers in Pharmacology, Vol. 16, 1693232, 2025.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022)

AU - Simoens, Steven

AU - Dodwell, David

AU - Hartevelt, Michael

AU - Lindgren, Peter

AU - Pistollato, Michele

AU - Pont, Lisa G.

AU - Pontes, Caridad

AU - Roediger, Alexander

AU - Sablek, Antun

AU - Van Ganse, Eric

AU - Wang, Qinyi

AU - Wenger, Chris

AU - Wilsdon, Tim

AU - Xoxi, Entela

AU - Godman, Brian

PY - 2025

Y1 - 2025

N2 - Author Entela Xoxi was erroneously assigned to affiliation Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom. This affiliation has now been removed for author Entela Xoxi. Author Lisa G. Pont was erroneously spelled as Lisa Pont. The original article has been updated.

AB - Author Entela Xoxi was erroneously assigned to affiliation Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom. This affiliation has now been removed for author Entela Xoxi. Author Lisa G. Pont was erroneously spelled as Lisa Pont. The original article has been updated.

KW - Australia

KW - Europe

KW - individual patient-level healthcare data

KW - oncology combination therapies

KW - pharmaceutical policy

KW - pricing and reimbursement

KW - utilization tracking

UR - https://www.scopus.com/pages/publications/105017232575

U2 - 10.3389/fphar.2025.1693232

DO - 10.3389/fphar.2025.1693232

M3 - Comment/debate

AN - SCOPUS:105017232575

SN - 1663-9812

VL - 16

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 1693232

ER -

Simoens S, Dodwell D, Hartevelt M, Lindgren P, Pistollato M, Pont LG et al. Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022). Frontiers in Pharmacology. 2025;16:1693232. doi: 10.3389/fphar.2025.1693232

Correction: The unexploited potential of data systems tracking medicines utilization: an opportunity to improve access to oncology combination therapies (Frontiers in Pharmacology, (2025), 16, (1532022), 10.3389/fphar.2025.1532022)

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this